Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.0B | 2.0B | 1.9B | 2.2B |
Cost of revenue | 1.2B | 1.2B | 1.2B | 1.3B |
Gross profit | 810M | 806M | 728M | 868M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 167M | 166M | 121M | 131M |
Operating income | 136M | 134M | 186M | 244M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 39M | 69M | 108M | 169M |
Tax provision | 11M | 21M | 24M | 37M |
Net income | 28M | 48M | 83M | 132M |
Basic EPS | 0.1 | 0.4 | 0.8 | 1.4 |
Diluted EPS | 0.1 | 0.4 | 0.8 | 1.4 |
Basic average shares | 79.4M | 79.4M | 79.4M | 79.4M |
Diluted average shares | 79.4M | 79.4M | 79.4M | 79.4M |
EBITDA | 244M | 237M | 286M | 345M |
Net income from continuing op. | 39M | 69M | 108M | 169M |
Minority interests | -2M | -2M | -4M | -3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |